- Samsung Biologics is one of 19 companies to have been awarded the 2022 Terra Carta Seal.
- The Terra Carta Seal recognises global companies which are driving innovation and demonstrating their commitment to, and momentum towards, the creation of genuinely sustainable markets.
- Designed by Sir Jony Ive, the Terra Carta Seal embodies the vision and ambition of His Majesty King Charles III and the Terra Carta, as a recovery plan for Nature, People and Planet.
- The Terra Carta Seal is underpinned by Corporate Knights’ Annual Global 100 Top Sustainable Corporations List and the wider principles of the Terra Carta.
INCHEON, South Korea, Jan. 11, 2023 /PRNewswire/ — Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), was awarded the Sustainable Markets Initiative’s Terra Carta Seal.
The Terra Carta Seal, launched at COP26 by His Majesty King Charles III when he was Prince of Wales, recognises global companies that are driving innovation and demonstrating their commitment to, and momentum towards, the creation of genuinely sustainable markets. It is being awarded to companies whose ambitions are aligned with those of the Terra Carta, a recovery plan for Nature, People and Planet, launched in January 2021.
Samsung Biologics affirmed its commitment to achieving net zero greenhouse gas emissions across its direct operations and supply chain by 2050 or earlier as part of its global response to climate change.
Due to the complex nature of bioprocessing, the company’s environmental management strategy outlines a number of core activities to reduce emissions, including process energy optimization, transitioning to renewable energy by investing in solar panels and utilizing external resources, converting to zero emission vehicles, and minimizing the use of disposables in the manufacturing process through waste management and recycling.
Samsung Biologics is also working to drive successful decarbonization by committing to 100% renewable power through the Climate Group’s RE100 initiative and adopting the recommendations of the Task Force on Climate-Related Financial Disclosures (TCFD) in reporting its climate actions progress.
John Rim, CEO and President, Samsung Biologics said: "We are honoured to be recognized with the Terra Carta Seal by the Sustainable Markets Initiative for Samsung Biologics’ contribution in working alongside our industry peers for this global effort. Healthcare is at a pivotal moment and through our collaborative efforts, we can contribute to shaping climate-resilient practices to influence and help shape policy across the pharmaceutical and healthcare sectors."
Brian Moynihan, Co-Chair, Sustainable Markets Initiative said: "The SMI brings CEOs together to work on the shared goals of accelerating our transition to a sustainable future. I congratulate those organizations recognized with the 2022 Terra Carta Seal and thank them for their commitment to sustainable markets."
The Terra Carta Seal acknowledges that each industry faces unique challenges in its transition to a sustainable future and they are all at different stages of their journey. And all industries and companies must be supported as they take steps in a more positive direction. At the same time, an accelerated pace is required if we are to achieve a 1.5-degree target, protect and restore biodiversity and benefit the lives and livelihoods of current and future generations.
Alongside its work to eliminate carbon emissions from its own operations, Samsung Biologics is engaging its suppliers as part of a broader initiative by the Supply Chains Working Group within the Sustainable Markets Initiative’s Health Systems Task Force to reduce direct emissions and identify carbon reduction options with the goal of reaching net zero in its supply chain. Last month, the Task Force announced joint action at COP27 to achieve near-term emissions reduction targets and published commitments to decarbonize through a series of whitepapers outlining practical recommendations and scalable actions for health systems stakeholders.
Sir Jony Ive and his creative team at LoveFrom created a physical and animated seal engineered with paper that is both simple and beautifully crafted. The design combines a host of natural references including oak leaves, fern, magnolia and honeybees and intricate patterns both in nature and in the arts, creating a visual celebration which reflects the power of and reverence for nature that is at the heart of the Terra Carta.
For more details and continuous updates on sustainability activities, please visit the Samsung Biologics’ Sustainability page.
For any press enquiries, please contact:
Senior Director of Marketing
About Samsung Biologics Co., Ltd.
Samsung Biologics (KRX: 207940.KS) is a fully integrated CDMO offering state-of-the-art contract development and manufacturing services. With proven regulatory approvals, the largest capacity, and the fastest throughput, Samsung Biologics is an award-winning partner of choice and is uniquely able to support the development and manufacturing of biologics products at every stage of the process while meeting the evolving needs of biopharmaceutical companies worldwide. For more information, visit samsungbiologics.com.
About the Terra Carta Seal
The Terra Carta Seal, launched at COP26, recognises global companies which are driving innovation and demonstrating their commitment to, and momentum towards, the creation of genuinely sustainable markets.
It is being awarded to companies whose ambitions are aligned with those of the Terra Carta, a recovery plan for Nature, People and Planet, launched in January 2021. Read more: https://www.sustainable-markets.org/terra-carta-seal/intro/
2022 Terra Carta Seal Recipients
Algonquin Power & Utilities Corp
Banco do Brasil SA
Evoqua Water Technologies Corp
KBC Groep NV
Schneider Electric SE
Schnitzer Steel Industries Inc
About the Sustainable Markets Initiative
In his former role as His Royal Highness The Prince of Wales, His Majesty King Charles III launched the Sustainable Markets Initiative (SMI) at Davos in January 2020 and the Terra Carta at the One Planet Summit in 2021. The Terra Carta serves as the mandate for the SMI.
The SMI is a network of global CEOs across industries working together to build prosperous and sustainable economies that generate long-term value through the balanced integration of natural, social, human, and financial capital. These global CEOs see themselves as the ‘Coalition of the Willing’ helping to lead their industries onto a more ambitious, accelerated, and sustainable trajectory. Read more: www.sustainable-markets.org
About the Terra Carta
In his former role as The Prince of Wales, His Majesty King Charles III, launched the Terra Carta at the One Planet Summit in January 2021. The Terra Carta serves as the mandate for the SMI and provides a practical roadmap for acceleration towards an ambitious and sustainable future; one that will harness the power of Nature combined with the transformative power, innovation, and resources of the private sector. Currently there are over 500 CEO-level supporters, including the Commonwealth and C40 cities. The Terra Carta has also served as the inspiration for the Terra Carta Design Lab. The Terra Carta is open to all countries, cities, companies, organizations, and schools who wish to support it. Read more: www.sustainable-markets.org/terra-carta
About LoveFrom and Sir Jony Ive:
LoveFrom is a creative collective of designers, architects, musicians, filmmakers, writers, engineers and artists with studios in London and San Francisco, California.
Sir Jony Ive KBE is a designer. Formerly the Chief Design Officer at Apple, he holds more than 12,500 patents worldwide, uniquely spanning user interface and hardware design. He is the Chancellor of the Royal College of Art.
For the Terra Carta Seal, LoveFrom worked with celebrated illustrator Peter Horridge, master printers and paper engineers Imprimerie du Marais and handmade paper specialists The Paper Foundation, founded by James Cropper. Los Angeles-based Method Studios created an animated version of the Terra Carta Seal.